Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup.
Saved in:
| Title: | Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. |
|---|---|
| Authors: | Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; University Hospitals Leuven, Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be., Gonzalez-Martin A; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Clinica Universidad de Navarra, Madrid, Spain; Program for Solid Tumors at Madrid, and Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain., Lorusso D; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy; Fondazione Policlinico Gemelli IRCCS, Rome, Italy., Gourley C; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Mirza MR; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark., Kurtz JE; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Strasbourg Cancer Institute, Strasbourg, France., Okamoto A; Japanese Gynecologic Oncology Group (JGOG), Tokyo, Japan; The Jikei University School of Medicine, Tokyo, Japan., Moore K; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; OU Health Stephenson Cancer Center, Oklahoma City, OH, USA., Kridelka F; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; Centre Hospitalier Universitaire de Liège, Liège, Belgium., McNeish I; National Cancer Research Institute (NCRI), London, UK; Department of Surgery and Cancer, Imperial College London, London, UK., Reuss A; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Coordinating Center for Clinical Trials, Philipps University, Marburg, Germany., Votan B; Association de Recherche Cancers Gynécologiques (ARCAGY)-GINECO, Paris, France., du Bois A; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Kliniken Essen Mitte (KEM), Essen, Germany., Mahner S; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; University Hospital, Ludwig Maximilians University, Munich, Germany., Ray-Coquard I; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Centre Leon Berard and University Claude Bernard Lyon I, Lyon, France., Kohn EC; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Berek JS; Women's Cancer Research Network-Cooperative Gynecologic Oncology Investigators (WCRN-COGI), Fresno, CA; Stanford Cancer Institute, Stanford, CA, USA., Tan DSP; Asia Pacific Gynecologic Oncology Trials Group (APGOT), Seoul, South Korea; Gynecologic Cancer Group Singapore (GCGS), Singapore; Cancer Science Institute, National University of Singapore, Singapore., Colombo N; Mario Negri Gynecologic Oncology (MaNGO), Milan, Italy; European Institute of Oncology, Milan, Italy; University of Milano-Bicocca, Milan, Italy., Zang R; Shanghai Gynecologic Oncology Group (SGOG), Shanghai, China; Zhongshan Hospital, Fudan University, Shanghai, China., Concin N; AGO -Austria, Innsbruck, Austria; Kliniken Essen Mitte (KEM), Essen, Germany; Medical University of Innsbruck, Innsbruck, Austria., O'Donnell D; Cancer Trials Ireland (CTI), Dublin, Ireland; St James's Hospital, Dublin, Ireland., Rauh-Hain A; Global Gynecologic Oncology Consortium (G-GOC), Houston, TX, USA; MD Anderson Cancer Center, The University of Texas, Houston, TX, USA., Herrington CS; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK., Marth C; AGO -Austria, Innsbruck, Austria; Medical University of Innsbruck, Innsbruck, Austria., Poveda A; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Hospital Quironsalud, Valencia, Spain., Fujiwara K; Gynecologic Cancer Clinical Trials and Investigation Consortium (GOTIC), North Kanto, Japan; Saitama Medical University International Medical Center, Saitama, Japan., Stuart GCE; Canadian Cancer Trials Group (CCTG), Kingston, ON, Canada; University of British Columbia, Vancouver, BC, Canada., Oza AM; Princess Margaret Hospital Consortium (PMHC), Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada., Bookman MA; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; San Francisco Medical Center, San Francisco, CA, USA. |
| Corporate Authors: | participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research |
| Source: | The Lancet. Oncology [Lancet Oncol] 2022 Aug; Vol. 23 (8), pp. e374-e384. |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't; Consensus Statement |
| Journal Info: | Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 35901833 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Vergote+I%22">Vergote I</searchLink>; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; University Hospitals Leuven, Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be.<br /><searchLink fieldCode="AU" term="%22Gonzalez-Martin+A%22">Gonzalez-Martin A</searchLink>; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Clinica Universidad de Navarra, Madrid, Spain; Program for Solid Tumors at Madrid, and Center for Applied Medical Research (CIMA), Universidad de Navarra, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lorusso+D%22">Lorusso D</searchLink>; Multicenter Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO), Naples, Italy; Fondazione Policlinico Gemelli IRCCS, Rome, Italy.<br /><searchLink fieldCode="AU" term="%22Gourley+C%22">Gourley C</searchLink>; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Mirza+MR%22">Mirza MR</searchLink>; Nordic Society of Gynecologic Oncology Clinical Trial Unit (NSGO-CTU), Copenhagen, Denmark; Rigshospitalet, Copenhagen, Denmark.<br /><searchLink fieldCode="AU" term="%22Kurtz+JE%22">Kurtz JE</searchLink>; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Strasbourg Cancer Institute, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Okamoto+A%22">Okamoto A</searchLink>; Japanese Gynecologic Oncology Group (JGOG), Tokyo, Japan; The Jikei University School of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Moore+K%22">Moore K</searchLink>; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; OU Health Stephenson Cancer Center, Oklahoma City, OH, USA.<br /><searchLink fieldCode="AU" term="%22Kridelka+F%22">Kridelka F</searchLink>; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; Centre Hospitalier Universitaire de Liège, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22McNeish+I%22">McNeish I</searchLink>; National Cancer Research Institute (NCRI), London, UK; Department of Surgery and Cancer, Imperial College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Reuss+A%22">Reuss A</searchLink>; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Coordinating Center for Clinical Trials, Philipps University, Marburg, Germany.<br /><searchLink fieldCode="AU" term="%22Votan+B%22">Votan B</searchLink>; Association de Recherche Cancers Gynécologiques (ARCAGY)-GINECO, Paris, France.<br /><searchLink fieldCode="AU" term="%22du+Bois+A%22">du Bois A</searchLink>; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; Kliniken Essen Mitte (KEM), Essen, Germany.<br /><searchLink fieldCode="AU" term="%22Mahner+S%22">Mahner S</searchLink>; Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) Study Group, Munich, Germany; University Hospital, Ludwig Maximilians University, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Ray-Coquard+I%22">Ray-Coquard I</searchLink>; Groupe d'Investigateurs National des Etudes des Cancers Ovariens et du Sein (GINECO), Paris, France; Centre Leon Berard and University Claude Bernard Lyon I, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Kohn+EC%22">Kohn EC</searchLink>; National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Berek+JS%22">Berek JS</searchLink>; Women's Cancer Research Network-Cooperative Gynecologic Oncology Investigators (WCRN-COGI), Fresno, CA; Stanford Cancer Institute, Stanford, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tan+DSP%22">Tan DSP</searchLink>; Asia Pacific Gynecologic Oncology Trials Group (APGOT), Seoul, South Korea; Gynecologic Cancer Group Singapore (GCGS), Singapore; Cancer Science Institute, National University of Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Colombo+N%22">Colombo N</searchLink>; Mario Negri Gynecologic Oncology (MaNGO), Milan, Italy; European Institute of Oncology, Milan, Italy; University of Milano-Bicocca, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Zang+R%22">Zang R</searchLink>; Shanghai Gynecologic Oncology Group (SGOG), Shanghai, China; Zhongshan Hospital, Fudan University, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Concin+N%22">Concin N</searchLink>; AGO -Austria, Innsbruck, Austria; Kliniken Essen Mitte (KEM), Essen, Germany; Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22O'Donnell+D%22">O'Donnell D</searchLink>; Cancer Trials Ireland (CTI), Dublin, Ireland; St James's Hospital, Dublin, Ireland.<br /><searchLink fieldCode="AU" term="%22Rauh-Hain+A%22">Rauh-Hain A</searchLink>; Global Gynecologic Oncology Consortium (G-GOC), Houston, TX, USA; MD Anderson Cancer Center, The University of Texas, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Herrington+CS%22">Herrington CS</searchLink>; Scottish Gynaecological Cancer Trials Group (SGCTG), Cancer Research UK, Edinburgh, UK; Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.<br /><searchLink fieldCode="AU" term="%22Marth+C%22">Marth C</searchLink>; AGO -Austria, Innsbruck, Austria; Medical University of Innsbruck, Innsbruck, Austria.<br /><searchLink fieldCode="AU" term="%22Poveda+A%22">Poveda A</searchLink>; Grupo Español de Cáncer de Ovario (GEICO), Madrid, Spain; Hospital Quironsalud, Valencia, Spain.<br /><searchLink fieldCode="AU" term="%22Fujiwara+K%22">Fujiwara K</searchLink>; Gynecologic Cancer Clinical Trials and Investigation Consortium (GOTIC), North Kanto, Japan; Saitama Medical University International Medical Center, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Stuart+GCE%22">Stuart GCE</searchLink>; Canadian Cancer Trials Group (CCTG), Kingston, ON, Canada; University of British Columbia, Vancouver, BC, Canada.<br /><searchLink fieldCode="AU" term="%22Oza+AM%22">Oza AM</searchLink>; Princess Margaret Hospital Consortium (PMHC), Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Bookman+MA%22">Bookman MA</searchLink>; Gynecologic Oncology Group-Foundation (GOG-F), Philadelphia, PA, USA; San Francisco Medical Center, San Francisco, CA, USA. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22participants+of+the+6th+Gynecologic+Cancer+InterGroup+%28GCIG%29+Ovarian+Cancer+Consensus+Conference+on+Clinical+Research%22">participants of the 6th Gynecologic Cancer InterGroup (GCIG) Ovarian Cancer Consensus Conference on Clinical Research</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100957246%22">The Lancet. Oncology</searchLink> [Lancet Oncol] 2022 Aug; Vol. 23 (8), pp. e374-e384. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review; Research Support, Non-U.S. Gov't; Consensus Statement – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Lancet+Pub%2E+Group%22">Lancet Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100957246 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1474-5488 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214702045%22">14702045 </searchLink><i>NLM ISO Abbreviation: </i>Lancet Oncol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35901833 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1470-2045(22)00139-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e374 Titles: – TitleFull: Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Vergote I – PersonEntity: Name: NameFull: Gonzalez-Martin A – PersonEntity: Name: NameFull: Lorusso D – PersonEntity: Name: NameFull: Gourley C – PersonEntity: Name: NameFull: Mirza MR – PersonEntity: Name: NameFull: Kurtz JE – PersonEntity: Name: NameFull: Okamoto A – PersonEntity: Name: NameFull: Moore K – PersonEntity: Name: NameFull: Kridelka F – PersonEntity: Name: NameFull: McNeish I – PersonEntity: Name: NameFull: Reuss A – PersonEntity: Name: NameFull: Votan B – PersonEntity: Name: NameFull: du Bois A – PersonEntity: Name: NameFull: Mahner S – PersonEntity: Name: NameFull: Ray-Coquard I – PersonEntity: Name: NameFull: Kohn EC – PersonEntity: Name: NameFull: Berek JS – PersonEntity: Name: NameFull: Tan DSP – PersonEntity: Name: NameFull: Colombo N – PersonEntity: Name: NameFull: Zang R – PersonEntity: Name: NameFull: Concin N – PersonEntity: Name: NameFull: O'Donnell D – PersonEntity: Name: NameFull: Rauh-Hain A – PersonEntity: Name: NameFull: Herrington CS – PersonEntity: Name: NameFull: Marth C – PersonEntity: Name: NameFull: Poveda A – PersonEntity: Name: NameFull: Fujiwara K – PersonEntity: Name: NameFull: Stuart GCE – PersonEntity: Name: NameFull: Oza AM – PersonEntity: Name: NameFull: Bookman MA IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2022 Aug Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1474-5488 Numbering: – Type: volume Value: 23 – Type: issue Value: 8 Titles: – TitleFull: The Lancet. Oncology Type: main |
| ResultId | 1 |